Lawson CA, Harter S, Bolaños BLG

Language: Spanish
References: 15
Page: 271-274
PDF size: 217.44 Kb.

ABSTRACT

Group B streptococcal (GBS) infections in newborns are subclassified into early and late-onset disease. Due to the implementation of GBS screening between the 35-37th week of pregnancy, mobility and mortality in newborns due to early onset disease has drastically declined. Indications for prophylaxis are based on history of previous GBS infant infection, culture results, birthing method as well as amniotic membrane integrity. Penicillin remains to be the most common antibiotic that is given.

REFERENCES

1. Barajas Viracachá, Norma Carolina and Báez, Martha. Enfermedad neonatal temprana por Streptococcus agalactiae en una unidad de recién nacidos, factores de riesgo maternofetales asociados a severidad y mortalidad. 3, 2011, Revista Ciencias de la Salud , Vol. 9, pp. 251-258.

2. Bennett, John E., Dolin, Raphael and Blaser, Martin. Mandell, Douglas and Bennett’s Principles and practice of Infectious Disease. 8vo. s.l. : Elsevier, 2015. pp. 2340-2345. Vol. 2.

3. CDC, National Center for Immunization and Respiratory Diseases, Division of Bacterial Diseases. Group B Strep. Centers for Disease Control and Prevention. [Online] marzo 16, 2012. [Cited: octubre 28, 2014.] www.cdc.gov/ groupbstrep/clinicians/clinicaloverview. html.

4. Centers for Disease Control and Prevention. Prevention of Perinatal Group B Streptococcal Disease: Revised Guidelines from CDC, 2010. s.l. : MMWR, 2010. 59(RR10);1-32.

5. Illuzzi, Jessica L. and Bracken, Michael . Duration of Intrapartum Prophylaxis for Neonatal Group B Streptococcal Disease. 5, Noviembre 2006, OBSTETRICS & GYNECOLOGY, Vol. 108.

6. Katz, Vern. Managment of group B Streptococcal infection. 4, 1993, Clinical obstetrics and gynecology, Vol. 36, pp. 832-842.

7. Lindhal, Gunnar, Areschoug, Thomas and Stalhammar-Carlemalm, Margaretha. Surface Proteins of Streptococcus agalactiae and related proteins in other Bacterial Pathogens. 1, enero 2005, Clinical microbiology reviews, Vol. 18.

8. Martinez, Maria Angelica, et al., et al. Serotipos y susceptibilidad antimicrobiana de streptococcus agalactiae. 132, Santiago : s.n., 2004, Revista medica de Chile. ISSN 0034- 9887.

9. Montibello, Silvia E., et al. Optimización de metodologías de cribaje para la búsqueda de Streptococcus agalactiae en embarazadas. 1, Ciudad Autónoma de Buenos Aires : s.n., ene./mar 2011, Revista Argentina de microbiologia, Vol. 43 . ISSN 0325-7541.

10. Mudorzi, J., Moyo, SR and Maeland, JA. Prevelance, capsular type distribution, anthropometric and obstetric factors of group B Streptococcus colonization in pregnancy. 5, 2000, Vol. 46. PMID 11210331.

11. Schrag, SJ, et al., et al. A population based comparison of strategies to prevent early-onset group B streptococcal disease in neontaes. 9, Julio 2002, New England Journal of Medicine, Vol. 233.

12. Schrag, Stephanie and Verani, Jennifer. Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccine. s.l. : Elsevier, 2012, Vaccine.

13. Sheehy, Annabel, Davis, Deborah and Homer, Caroline S.E. s.l. Assisting women to make informed choices about screening for Group B Streptococcus in pregnanxy: a critical review of the evidence: Elsevier, octubre 2012, Women and Birth, Vol. 26, pp. 152-157.

14. The American College of Obstetricians and Gynecologists. Prevention of Early-Onset Group B Streptococcal. 2011. pp. 1019–27.

15. Valkenburg-van den Berg, Arijaan W. , et al. Timing of Group B Streptococcus Screening in Pregnancy: A Systematic Review. 2010, Karger, Vol. 69, pp. 174–183 .